In these contexts of chronic stimulation, T cells upregulate inhibitory molecules such as PD‐1 and CTLA‐4, and their engagement, either on anti‐tumor T cells or TREG, results in changes in FAO and glycolysis [54, 55, 56, 57]. This evidence concerns the gene PDCD1 and neoplasm.